Split intein-based gene therapies for two types of congenital blindness

DISEASE CATEGORY: Ophthalmic disease

INDICATION: Blindness

Mouse studies suggest gene therapies delivering ABCA4 or CEP290 as split inteins could help treat Stargardt

Read the full 209 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE